Imugene Ltd

• 2023 Prevention of metastasis formation by combination therapy targeting Her2 and PD-L1 in Her2-expressing tumors based on observed efficacious vaccination against Her2-positive tumors.

Download
 RDF/XML-Format
 JSON-LD-Format
 Turtle-Format
 N3-Format